Pfizer announces agreement with Gilead to manufacture Remdesivir – COVID-19 Treatment

NEW YORK (STL.News) Pfizer Inc. (NYSE: PFE) today announced a multi-year agreement with Gilead Sciences, Inc.…

Peer-Reviewed Data Shows Remdesivir for COVID-19 Improves Time to Recovery

Preliminary Results from NIH Clinical Trial Published Bethesda, MD (STL.News) The investigational antiviral remdesivir is superior…